SEARCH

SEARCH BY CITATION

References

  • 1
    Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L.-X., Cohen, P. A. and Shu, S., Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 2008. 181: 32913300.
  • 2
    Kusmartsev, S. and Gabrilovich, D., Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol. Immunother. 2006. 55: 237245.
  • 3
    Youn, J.-I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 57915802.
  • 4
    Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162174.
  • 5
    Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. and Van Ginderachter, J. A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity. Blood 2008. 111: 42334244.
  • 6
    Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L. et al., Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 2007. 13: 828835.
  • 7
    Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R. and Zhang, H.-G., Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007. 109: 43364342.
  • 8
    Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M. and Chen, S.-H., Gr-1+CD115 +immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 11231131.
  • 9
    Serafini, P., Mgebroff, S., Noonan, K. and Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008. 68: 54395449.
  • 10
    Pan, P.-Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M. and Chen, S.-H., Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 2010. 70: 99108.
  • 11
    Bronte, V. and Zanovello, P., Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005. 5: 641654.
  • 12
    Qi, C., Cai, Y., Gunn, L., Ding, C., Li, B., Kloecker, G., Qian, K. et al., Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood 2011. 117: 68256836.
  • 13
    Li, B., Cai, Y., Qi, C., Hansen, R., Ding, C., Mitchell, T. C. and Yan, J., Orally administered particulate β-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin. Cancer Res. 2010. 16: 51535164.
  • 14
    Baran, J., Allendorf, D. J., Hong, F. and Ross, G. D., Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem. Cytobiol. 2007. 45: 107114.
  • 15
    Taylor, P. R., Brown, G. D., Reid, D. M., Willment, J. A., Martinez-Pomares, L., Gordon, S. and Wong, S. Y. C., The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 2002. 169: 38763882.
  • 16
    Brown, G. D., Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 2006. 6: 3343.
  • 17
    Goodridge, H. S., Simmons, R. M. and Underhill, D. M., Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 2007. 178: 31073115.
  • 18
    LeibundGut-Landmann, S., Grosz, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E. et al., Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007. 8: 630638.
  • 19
    Rogers, N. C., Slack, E. C., Edwards, A. D., Nolte, M. A., Schulz, O., Schweighoffer, E., Williams, D. L. et al., Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 2005. 22: 507517.
  • 20
    Underhill, D. M., Rossnagle, E., Lowell, C. A. and Simmons, R. M., Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005. 106: 25432550.
  • 21
    Reid, D. M., Gow, N. A. R. and Brown, G. D., Pattern recognition: recent insights from dectin-1. Curr. Opinion Immunol. 2009. 21: 3037.
  • 22
    LeibundGut-Landmann, S., Osorio, F., Brown, G. D. and Reis e Sousa, C., Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 2008. 112: 49714980.
  • 23
    Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. J. and Gordon, S., Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 2003. 197: 11191124.
  • 24
    Thornton, B., Vetvicka, V., Pitman, M., Goldman, R. and Ross, G., Analysis of the sugar specificity and molecular location of the beta- glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 1996. 156: 12351246.
  • 25
    Li, B., Allendorf, D. J., Hansen, R., Marroquin, J., Ding, C., Cramer, D. E. and Yan, J., Yeast β-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J. Immunol. 2006. 177: 16611669.
  • 26
    Hong, F., Yan, J., Baran, J. T., Allendorf, D. J., Hansen, R. D., Ostroff, G. R., Xing, P. X. et al., Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 2004. 173: 797806.
  • 27
    Liu, J., Gunn, L., Hansen, R. and Yan, J., Combined yeast-derived β-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp. Mol. Pathol. 2009. 86: 208214.
  • 28
    Dillon, S., Agrawal, S., Banerjee, K., Letterio, J., Denning, T. L., Oswald-Richter, K., Kasprowicz, D. J. et al., Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 2006. 116: 916928.
  • 29
    Karumuthil-Melethil, S., Perez, N., Li, R. and Vasu, C., Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J. Immunol. 2008. 181: 83238334.
  • 30
    Kusmartsev, S. and Gabrilovich, D., Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev. 2006. 25: 323331.
  • 31
    Nagaraj, S. and Gabrilovich, D. I., Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 2008. 68: 25612563.
  • 32
    Zoglmeier, C., Bauer, H., Nörenberg, D., Wedekind, G., Bittner, P., Sandholzer, N., Rapp, M. et al., CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin. Cancer Res. 2011. 17: 17651775.
  • 33
    Hara, H., Ishihara, C., Takeuchi, A., Imanishi, T., Xue, L., Morris, S. W., Inui, M. et al., The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 2007. 8: 619629.
  • 34
    Kusmartsev, S., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E., Lush, R. and Gabrilovich, D., All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 2003. 63: 44414449.
  • 35
    Kodumudi, K. N., Woan, K., Gilvary, D. L., Sahakian, E., Wei, S. and Djeu, J. Y., A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin. Cancer Res. 2010. 16: 45834594.
  • 36
    Tian, J., Ma, J., Wang, S., Yan, J., Chen, J., Tong, J., Wu, C. et al., Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation. Cell. Immunol. 2011. 270: 183187.